Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Radical prostatectomy in men less than 50 years old.

M A Riopel1, T J Polascik, A W Partin

  • 1Department of Pathology, The Johns Hopkins University School of Medicine, USA; Department of Urology, The Johns Hopkins University School of Medicine, USA; James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA.

Urologic Oncology
|January 13, 2011
PubMed
Summary

Younger men (<50) undergoing radical prostatectomy for prostate cancer show slightly less tumor progression, particularly in the first five years post-surgery. This is linked to fewer positive surgical margins, suggesting favorable outcomes for younger patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.

Prostate cancer and prostatic diseases·2017
Same author

Very-high-risk localized prostate cancer: definition and outcomes.

Prostate cancer and prostatic diseases·2013
Same author

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.

The Journal of urology·2007
Same author

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer.

Reviews in urology·2006
Same author

Cyclooxygenase-2 as a marker for prostate cancer.

Reviews in urology·2006

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • Age is a significant factor in prostate cancer prognosis.
  • Radical prostatectomy is a primary treatment for localized prostate cancer.
  • Understanding age-related differences in outcomes is crucial for patient counseling and treatment planning.

Purpose of the Study:

  • To investigate the impact of patient age on tumor progression after radical prostatectomy.
  • To compare oncological outcomes between younger (<50 years) and older (>50 years) men treated for prostate cancer.

Main Methods:

  • Retrospective analysis of 543 men undergoing radical prostatectomy for clinically localized prostate cancer.
  • Patients stratified into two age groups: <50 years (N=85) and >50 years (N=458).

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

  • Kaplan-Meier analysis used to assess tumor progression (defined as prostate-specific antigen elevation) with a mean follow-up of 5.3 years.
  • Main Results:

    • Younger men (<50) exhibited slightly less tumor progression (p=0.04), especially within the first 5 years post-surgery.
    • Lower incidence of positive surgical margins in the younger group (18.8%) compared to the older group (42.6%; p<0.0001).
    • Higher incidence of lymph node metastasis in younger men (14.1%) vs. older men (6.1%; p=0.01), though this did not significantly impact overall progression.

    Conclusions:

    • Younger men undergoing radical prostatectomy for prostate cancer do not have a worse prognosis.
    • Age appears to influence surgical margin status, potentially due to differences in gland size.
    • Younger patients may experience better outcomes in the initial postoperative period following radical prostatectomy.